Consensus of gastroesophageal reflux disease in Taiwan with endoscopy-based approach covered by National Health Insurance

Bor Shyang Sheu, Cheng Tang Chiu, Yi Chia Lee, Chi Yang Chang, Deng Chyang Wu, Jyh Ming Liou, Ming Shiang Wu, Wei Lun Chang, Chun Ying Wu, Jaw Town Lin

研究成果: Article

3 引文 (Scopus)

摘要

Summary Background and aims Gastroesophageal reflux disease (GERD) is emerging as a clinical complication in the Orient. The consensus comprises recommendations to GERD control under the advantage of endoscopy-based approach covered by the Taiwan National Health Insurance. Methods The steering committee defined the consensus scope to cover diagnostic, therapeutic, unresolved, controversial, or long-term proton pump inhibitor-related issues to GERD. The literature review emphasized domestic data, after which the draft statements and statement evidence levels were defined. Thirty-five experts of GERD in Taiwan formed the expert group to conduct the consensus conference by a modified Delphi process to vote anonymously to reach a consensus, defined by an agreement of ≥ 80% for each statement, and to set the recommendation grade. Results The consensus included 22 statements, including seven on diagnostic approach, seven on therapeutic suggestion, and eight on unresolved, controversial, or long-term proton pump inhibitor-related issues to GERD. The consensus highlighted that the endoscopy approach to GERD can define the disease spectrum and exclude malignant potential. The questionnaire survey can not only define GERD, but also monitor treatment response and quality of life. The consensus addressed suggestions for the unresolved issues related to extraesophageal presentation and adverse concerns of GERD after long-term use of proton pump inhibitors. In the endemic area of upper gastrointestinal cancers, Helicobacter pylori eradication is suggested to reduce progression of gastric precancerous lesions, and endoscopic surveillance of Barrett's esophagus with dysplasia deserves prospective research. Conclusion The consensus comprises recommendations for the management of GERD in a high upper gastrointestinal cancer area with a national coverage of endoscopic approach.

原文English
文章編號79
頁(從 - 到)85-94
頁數10
期刊Advances in Digestive Medicine
2
發行號3
DOIs
出版狀態Published - 2015 九月 1

指紋

National Health Programs
Gastroesophageal Reflux
Taiwan
Endoscopy
Proton Pump Inhibitors
Gastrointestinal Neoplasms
Barrett Esophagus
Helicobacter pylori
Stomach
Quality of Life
Therapeutics

All Science Journal Classification (ASJC) codes

  • Gastroenterology

引用此文

Sheu, Bor Shyang ; Chiu, Cheng Tang ; Lee, Yi Chia ; Chang, Chi Yang ; Wu, Deng Chyang ; Liou, Jyh Ming ; Wu, Ming Shiang ; Chang, Wei Lun ; Wu, Chun Ying ; Lin, Jaw Town. / Consensus of gastroesophageal reflux disease in Taiwan with endoscopy-based approach covered by National Health Insurance. 於: Advances in Digestive Medicine. 2015 ; 卷 2, 編號 3. 頁 85-94.
@article{641c97a974754e769e56fed6d2f7f495,
title = "Consensus of gastroesophageal reflux disease in Taiwan with endoscopy-based approach covered by National Health Insurance",
abstract = "Summary Background and aims Gastroesophageal reflux disease (GERD) is emerging as a clinical complication in the Orient. The consensus comprises recommendations to GERD control under the advantage of endoscopy-based approach covered by the Taiwan National Health Insurance. Methods The steering committee defined the consensus scope to cover diagnostic, therapeutic, unresolved, controversial, or long-term proton pump inhibitor-related issues to GERD. The literature review emphasized domestic data, after which the draft statements and statement evidence levels were defined. Thirty-five experts of GERD in Taiwan formed the expert group to conduct the consensus conference by a modified Delphi process to vote anonymously to reach a consensus, defined by an agreement of ≥ 80{\%} for each statement, and to set the recommendation grade. Results The consensus included 22 statements, including seven on diagnostic approach, seven on therapeutic suggestion, and eight on unresolved, controversial, or long-term proton pump inhibitor-related issues to GERD. The consensus highlighted that the endoscopy approach to GERD can define the disease spectrum and exclude malignant potential. The questionnaire survey can not only define GERD, but also monitor treatment response and quality of life. The consensus addressed suggestions for the unresolved issues related to extraesophageal presentation and adverse concerns of GERD after long-term use of proton pump inhibitors. In the endemic area of upper gastrointestinal cancers, Helicobacter pylori eradication is suggested to reduce progression of gastric precancerous lesions, and endoscopic surveillance of Barrett's esophagus with dysplasia deserves prospective research. Conclusion The consensus comprises recommendations for the management of GERD in a high upper gastrointestinal cancer area with a national coverage of endoscopic approach.",
author = "Sheu, {Bor Shyang} and Chiu, {Cheng Tang} and Lee, {Yi Chia} and Chang, {Chi Yang} and Wu, {Deng Chyang} and Liou, {Jyh Ming} and Wu, {Ming Shiang} and Chang, {Wei Lun} and Wu, {Chun Ying} and Lin, {Jaw Town}",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.aidm.2015.05.002",
language = "English",
volume = "2",
pages = "85--94",
journal = "Advances in Digestive Medicine",
issn = "2351-9797",
publisher = "Elsevier Taiwan LLC",
number = "3",

}

Consensus of gastroesophageal reflux disease in Taiwan with endoscopy-based approach covered by National Health Insurance. / Sheu, Bor Shyang; Chiu, Cheng Tang; Lee, Yi Chia; Chang, Chi Yang; Wu, Deng Chyang; Liou, Jyh Ming; Wu, Ming Shiang; Chang, Wei Lun; Wu, Chun Ying; Lin, Jaw Town.

於: Advances in Digestive Medicine, 卷 2, 編號 3, 79, 01.09.2015, p. 85-94.

研究成果: Article

TY - JOUR

T1 - Consensus of gastroesophageal reflux disease in Taiwan with endoscopy-based approach covered by National Health Insurance

AU - Sheu, Bor Shyang

AU - Chiu, Cheng Tang

AU - Lee, Yi Chia

AU - Chang, Chi Yang

AU - Wu, Deng Chyang

AU - Liou, Jyh Ming

AU - Wu, Ming Shiang

AU - Chang, Wei Lun

AU - Wu, Chun Ying

AU - Lin, Jaw Town

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Summary Background and aims Gastroesophageal reflux disease (GERD) is emerging as a clinical complication in the Orient. The consensus comprises recommendations to GERD control under the advantage of endoscopy-based approach covered by the Taiwan National Health Insurance. Methods The steering committee defined the consensus scope to cover diagnostic, therapeutic, unresolved, controversial, or long-term proton pump inhibitor-related issues to GERD. The literature review emphasized domestic data, after which the draft statements and statement evidence levels were defined. Thirty-five experts of GERD in Taiwan formed the expert group to conduct the consensus conference by a modified Delphi process to vote anonymously to reach a consensus, defined by an agreement of ≥ 80% for each statement, and to set the recommendation grade. Results The consensus included 22 statements, including seven on diagnostic approach, seven on therapeutic suggestion, and eight on unresolved, controversial, or long-term proton pump inhibitor-related issues to GERD. The consensus highlighted that the endoscopy approach to GERD can define the disease spectrum and exclude malignant potential. The questionnaire survey can not only define GERD, but also monitor treatment response and quality of life. The consensus addressed suggestions for the unresolved issues related to extraesophageal presentation and adverse concerns of GERD after long-term use of proton pump inhibitors. In the endemic area of upper gastrointestinal cancers, Helicobacter pylori eradication is suggested to reduce progression of gastric precancerous lesions, and endoscopic surveillance of Barrett's esophagus with dysplasia deserves prospective research. Conclusion The consensus comprises recommendations for the management of GERD in a high upper gastrointestinal cancer area with a national coverage of endoscopic approach.

AB - Summary Background and aims Gastroesophageal reflux disease (GERD) is emerging as a clinical complication in the Orient. The consensus comprises recommendations to GERD control under the advantage of endoscopy-based approach covered by the Taiwan National Health Insurance. Methods The steering committee defined the consensus scope to cover diagnostic, therapeutic, unresolved, controversial, or long-term proton pump inhibitor-related issues to GERD. The literature review emphasized domestic data, after which the draft statements and statement evidence levels were defined. Thirty-five experts of GERD in Taiwan formed the expert group to conduct the consensus conference by a modified Delphi process to vote anonymously to reach a consensus, defined by an agreement of ≥ 80% for each statement, and to set the recommendation grade. Results The consensus included 22 statements, including seven on diagnostic approach, seven on therapeutic suggestion, and eight on unresolved, controversial, or long-term proton pump inhibitor-related issues to GERD. The consensus highlighted that the endoscopy approach to GERD can define the disease spectrum and exclude malignant potential. The questionnaire survey can not only define GERD, but also monitor treatment response and quality of life. The consensus addressed suggestions for the unresolved issues related to extraesophageal presentation and adverse concerns of GERD after long-term use of proton pump inhibitors. In the endemic area of upper gastrointestinal cancers, Helicobacter pylori eradication is suggested to reduce progression of gastric precancerous lesions, and endoscopic surveillance of Barrett's esophagus with dysplasia deserves prospective research. Conclusion The consensus comprises recommendations for the management of GERD in a high upper gastrointestinal cancer area with a national coverage of endoscopic approach.

UR - http://www.scopus.com/inward/record.url?scp=84983116906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983116906&partnerID=8YFLogxK

U2 - 10.1016/j.aidm.2015.05.002

DO - 10.1016/j.aidm.2015.05.002

M3 - Article

AN - SCOPUS:84983116906

VL - 2

SP - 85

EP - 94

JO - Advances in Digestive Medicine

JF - Advances in Digestive Medicine

SN - 2351-9797

IS - 3

M1 - 79

ER -